Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Non-Current Deffered Revenue (2016 - 2021)

Chemours (CC) has 7 years of Non-Current Deffered Revenue data on record, last reported at $2.0 million in Q4 2021.

  • For Q4 2021, Non-Current Deffered Revenue fell 60.0% year-over-year to $2.0 million; the TTM value through Dec 2021 reached $2.0 million, down 60.0%, while the annual FY2021 figure was $2.0 million, 60.0% down from the prior year.
  • Non-Current Deffered Revenue reached $2.0 million in Q4 2021 per CC's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $8.0 million in Q3 2018 and bottomed at $2.0 million in Q4 2021.
  • Average Non-Current Deffered Revenue over 5 years is $5.5 million, with a median of $5.0 million recorded in 2018.
  • Peak YoY movement for Non-Current Deffered Revenue: increased 20.0% in 2017, then tumbled 60.0% in 2021.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $6.0 million in 2017, then grew by 16.67% to $7.0 million in 2018, then rose by 14.29% to $8.0 million in 2019, then crashed by 37.5% to $5.0 million in 2020, then crashed by 60.0% to $2.0 million in 2021.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $2.0 million in Q4 2021, $5.0 million in Q3 2021, and $5.0 million in Q2 2021.